BIOMAT Database Logo BIOMAT Database Logo

Evaluation of vinblastine administered by 5-day continuous infusion in women with advanced breast cancer. 1984

J N Ingle, and D L Ahmann, and J G Gerstner, and S J Green, and M J O'Connell, and L K Kvols

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J N Ingle, and D L Ahmann, and J G Gerstner, and S J Green, and M J O'Connell, and L K Kvols
Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer.
January 1980, Cancer treatment reports,
J N Ingle, and D L Ahmann, and J G Gerstner, and S J Green, and M J O'Connell, and L K Kvols
Failure of 5-day vinblastine infusion in the treatment of patients with advanced refractory breast cancer.
September 1982, Cancer treatment reports,
J N Ingle, and D L Ahmann, and J G Gerstner, and S J Green, and M J O'Connell, and L K Kvols
Five-day continuous-infusion vinblastine in the treatment of breast cancer.
July 1985, Cancer,
J N Ingle, and D L Ahmann, and J G Gerstner, and S J Green, and M J O'Connell, and L K Kvols
Continuous 5-day infusion of vinblastine for percutaneous hepatic arterial chemotherapy for metastatic breast cancer.
November 1987, Cancer treatment reports,
J N Ingle, and D L Ahmann, and J G Gerstner, and S J Green, and M J O'Connell, and L K Kvols
Pharmacokinetics of trimetrexate administered by five-day continuous infusion to patients with advanced cancer.
June 1987, Cancer research,
J N Ingle, and D L Ahmann, and J G Gerstner, and S J Green, and M J O'Connell, and L K Kvols
Pharmacokinetics and toxicity of 5-day continuous infusion of vinblastine.
January 1984, Cancer chemotherapy and pharmacology,
J N Ingle, and D L Ahmann, and J G Gerstner, and S J Green, and M J O'Connell, and L K Kvols
Combination chemotherapy with continuous infusion vinblastine and peptichemio for patients with advanced metastatic breast cancer.
October 1982, American journal of clinical oncology,
J N Ingle, and D L Ahmann, and J G Gerstner, and S J Green, and M J O'Connell, and L K Kvols
Phase II study of continuous 5-day vinblastine infusion in renal adenocarcinoma.
June 1984, Cancer treatment reports,
J N Ingle, and D L Ahmann, and J G Gerstner, and S J Green, and M J O'Connell, and L K Kvols
Continuous venous infusion of vinblastine in metastatic breast cancer.
January 1991, Chemotherapy,
J N Ingle, and D L Ahmann, and J G Gerstner, and S J Green, and M J O'Connell, and L K Kvols
Evaluation of bisantrene administered by 72-hour infusion in women with metastatic breast cancer.
October 1986, American journal of clinical oncology,
Copied contents to your clipboard!